Pharmaceutics 2013, 5(2), 220-231; doi:10.3390/pharmaceutics5020220

Glutathione Transferase (GST)-Activated Prodrugs

Institute of Biomolecular Chemistry of CNR, Padova Unit, Via Marzolo 1, Padova 35131, Italy
* Author to whom correspondence should be addressed.
Received: 28 February 2013; in revised form: 21 March 2013 / Accepted: 22 March 2013 / Published: 2 April 2013
(This article belongs to the Special Issue Prodrugs)
PDF Full-text Download PDF Full-Text [417 KB, uploaded 2 April 2013 14:52 CEST]
Abstract: Glutathione transferase (formerly GST) catalyzes the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione. Moreover, several data link the overexpression of some GSTs, in particular GSTP1-1, to both natural and acquired resistance to various structurally unrelated anticancer drugs. Tumor overexpression of these proteins has provided a rationale for the search of GST inhibitors and GST activated cytotoxic prodrugs. In the present review we discuss the current structural and pharmacological knowledge of GST-activated cytotoxic compounds.
Keywords: glutatione transferase; glutathione; anticancer prodrugs

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Ruzza, P.; Calderan, A. Glutathione Transferase (GST)-Activated Prodrugs. Pharmaceutics 2013, 5, 220-231.

AMA Style

Ruzza P, Calderan A. Glutathione Transferase (GST)-Activated Prodrugs. Pharmaceutics. 2013; 5(2):220-231.

Chicago/Turabian Style

Ruzza, Paolo; Calderan, Andrea. 2013. "Glutathione Transferase (GST)-Activated Prodrugs." Pharmaceutics 5, no. 2: 220-231.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert